O’FALLON, Mo.--(BUSINESS WIRE)--Synergetics USA, Inc. (NASDAQ: SURG) today announced it expects to report growth in sales and net income for the first fiscal quarter ended October 31, 2011, compared with the first quarter of the prior year.
Synergetics expects to report revenue of $13.3 million to $13.6 million in the first quarter of fiscal 2012, representing approximately a 10%-13% increase in revenue compared with the first quarter of fiscal 2011. The growth in revenue was driven primarily by higher sales of domestic ophthalmology products, including increased sales of core products and procedural pack business compared with the first quarter of last year. In addition, the revenue growth was attributable to increased sales to the Company’s marketing partners.
Synergetics expects to report revenue of $13.3 million to $13.6 million in the first quarter of fiscal 2012, representing approximately a 10%-13% increase in revenue compared with the first quarter of fiscal 2011. The growth in revenue was driven primarily by higher sales of domestic ophthalmology products, including increased sales of core products and procedural pack business compared with the first quarter of last year. In addition, the revenue growth was attributable to increased sales to the Company’s marketing partners.
